A new type of mRNA vaccine is more scalable and adaptable to continuously evolving viruses such as SARS-CoV-2 and H5N1, according to a new study.
New mRNA vaccine is more effective and less costly to develop
- Post author:Annie Holland
- Post published:June 4, 2025
- Post category:News Feed
- Post comments:0 Comments